Zusammenfassung
In der letzten Dekade ist es durch molekulargenetische Analysen zu erheblichen Fortschritten in unserem Verständnis über primär elektrische Herzerkrankungen gekommen. Das angeborene Long-QT-Syndrom (LQTS) und das kürzlich beschriebene Short-QTSyndrom (SQTS) werden durch eine Dysfunktion kardialer Ionenkanäle hervorgerufen. Die daraus resultierenden Repolarisationsstörungen führen zu einer abnormalen Verlängerung oder Verkürzung der QTc-Zeit im EKG. Diese Ionenkanalerkrankungen zeigen ein hohes Maß an genetischer Heterogenität, welche sich durch eine enorme Variabilität der Genotyp-Phänotyp Relation äußert. Im Folgenden haben wir einen kurzen, klinisch gewichteten Überblick über den aktuellen Wissensstand der molekularen Grundlagen des LQTS und SQTS zusammengestellt.
Summary
In the past decade molecular genetic analysis has greatly expanded our knowledge about inherited arrhythmogenic syndromes. The congenital long QT syndrome (LQTS) and the recently described short QT syndrome (SQTS), with the defining characteristic of abnormal prolongation or shortening of the QTc interval on the surface electrocardiogram, are caused by cardiac ion channel dysfunctions. These “channelopathies” show a high degree of genetic heterogeneity of the molecular pathways in terms of the relationships between genetic defects and phenotypic expression. In this brief review we summarize the current understanding of the molecular basis of long and short QT syndrome with focus on the impact of molecular genetics on the clinical management of these diseases.
Literatur
Splawski I, Shen J, Timothy KW, Vincent M, Keating MT et al (2000) Spectrum of mutations in long QT syndrome genes. Circulation 102:1178–1185
Moss AJ, Kass RS (2005) Long QT syndrome: from channels to cardiac arrhythmias. J Clin Invest 115:2018–2024
Kääb S, Schulze-Bahr E (2005) Susceptibility genes and modifiers for cardiac arrhythmias. Cardiovasc Res 67:397–413
Mohler PJ, Splawski I, Napolitano C, Timothy K, Priori S, Keating MT, Bennett V et al (2004) A cardiac arrhythmia syndrome caused by loss of ankyrin-B function. PNAS 24:9137–9142
Plaster NM, Tawil R, Tristani-Firouzi M et al (2001) Mutations in Kir2.1 cause the developmental and episodic electrical phenotypes of Anderson Syndrome. Cell 105:511–519
Tristani-Firouzi M, Jensen JL, Donaldson MR et al (2002) Functional and clinical characterization of KCNJ2 mutations associated with LQT7 (Anderson syndrome). J Clin Invest 110:381–388
Splawski I, Timothy KW, Sharpe LM et al (2004) Cav1.2 calcium channel dysfunction causes multisystem disorder including arrhythmia and autism. Cell 119:19–31
Priori S, Napolitano C, Vicentini A (2002) Inherited arrhythmia syndromes: applying the molecular biology and genetic to the clinical management. J of Interv cardiac Electrophysiol 9:93–101
Moss AJ, Schwartz PJ (2005) 25th anniversary of the international long QT syndrome registry. Circulation 111:1199–1201
Priori S, Schwartz PJ, Napolitano C, Capelletti D et al (2003) Risk stratification in the long QT syndrome. N Engl J Med 348:1866–1874
Zareba W, Moss AJ, Schwartz PJ, Vincent GM, Priori S, Keating MT, Hall WJ et al (1998) Influence of the genotype on the clinical course of the long QT syndrome. N Engl J Med 339:960–965
Vincent GM (2005) Risk assessment in long QT syndrome: the achilles heel of appropriate treatment. Heart Rhythm 2(5):505–506
Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M, Gregoratos G, Klein G, Moss AJ, Myerburg RJ, Priori SG, Quinones MA, Roden DM, Silka MJ, Tracy C et al (2006) ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death. Eur Heart J 27:2099-2140
Moss AJ, Zareba W, Kaufman E, Zang L, Wang Z et al (2002) Increased risk of arrhythmic events in long QT syndrome with mutations in the pore region of the human ether-a-go-go-related gene potassium channel. Circulation 105:794–799
Rossenbacker T, Mubagwa K, Heidbüchel H, Carmeliet P et al (2005) Novel mutation in the per-arnt-sim domain of KCNH2 causes a malignant form of the long QT syndrome. Circulation 111:961–968
Westenkov P, Splawski I, Timothy K, Keating MT, Sanguinetti MC (2004) Compound mutations. A common cause of severe long QT syndrome. Circulation 109:1834–1841
Kimbrough J, Moss AJ, Zareba W, Robinson JL, Zhang L et al (2001) Clinical implications for affected parents and siblings of probands with long QT syndrome. Circulation 104:557–562
Priori S, Napolitano C, Schwartz PJ (1999) Low penetrance in the long QT syndrome. Circulation 99:529–533
Moss AJ, Zareba W, Hall WJ, Andrews ML et al (2000) Effectiveness and limitations of betablocker therapy in congenital long-QT syndrome. Circulation 101:616–623
Schwartz PJ, Priori S, Cerrone M, Zareba W, Epstein AE, Li C, Hu D et al (2004) Left cardiac sympathetic denervation in the management if highrisk patients affected by the long QT syndrome. Circulation 109:1826–1833
Dorostkar PC, Eldar M, Belhassen B, Scheinman MM (1999) Long-term follow-up of patients with long QT syndrome with betablocker and continuous pacing. Circulation 100:2431–2436
Mönnig G, Köbe J, Löher A, Eckardt L, Breithardt G, Schulze-Bahr E, Böcker D et al (2005) Implantable cardioverter-defibrillator therapy in patients with congenital long QT syndrome: a long term follow up. Heart Rhythm 2:497–504
Rajamani S, Anderson CL, Anson BD, January CT (2002) Pharmacological rescue of human K channel long QT2 mutations. Circulation 105:2830–2835
Gepstein L, Feld Y, Yankelson L (2004) Somatic gene and cell therapy strategies for the treatment of cardiac arrhythmias. Am J Physiol 286:H815–822
Phillips KA, Ackerman MJ, Sakowski J, Berul CI (2005) Cost-effectiveness analysis of genetic testing for familial long QT syndrome in symptomatic index cases. Heart Rhythm 2:1294–1300
Gussak I, Brugada P, Brugada J et al (2000) Idiopathic short QT interval: a new clinical syndrome? Cardiology 94:99–102
Brugada R, Hong K, Dumaine R, Brugada P, Antzelevitch C et al (2004) Sudden death associated with short QT syndrome linked to mutations in HERG. Circulation 109:30–35
Bellocq C, van Ginneken ACG, Bezzina CR, Wilde AA et al (2004) Mutation in the KCNQ1 gene leading to the short QT-interval syndrome. Circulation 109:2394–2397
Priori S, Pandit SV, Rivolta I, Berenfeld O, Jalife J et al (2005) A novel form of short QT syndrome (SQT3) is caused by a mutation in the KCNJ2 gene. Circ Res 96:800–807
Schulze-Bahr E (2005) Short QT syndrome or Andersen syndrome. Yin and Yang of Kir2.1 channel dysfunction. Circ Res 96:703–704
Cerrone M, Noujaim S, Jalife J (2006) The short QT syndrome as a paradigm to understand the role of potassium channels in ventricular fibrillation. J Intern Med 259:24–38
Schimpf R, Bauersfeld U, Gaita F, Wolpert C (2005) Short QT syndrome: successful prevention of sudden death in an adolescent by implantable cardioverter-defibrillator treatment for primary prophylaxis. Heart Rhythm 2:416–417
Gaita F, Giustetto C, Bianchi F, Wolpert C, Schimpf R, Haissaguerre M, Calo L, Brugada R, Antzelevitch C, Borggrefe M, Wolpert C (2004) Short QT syndrome: pharmacological treatment. J Am Coll Cardiol 43:1494–1499
Gaita F, Giustetto C, Bianchi F, Wolpert C, Schimpf R, Riccardi R, Grossi S, Richardi E, Borggrefe M (2003) Short QT syndrome: a familial cause of sudden death. Circulation 108:965–970
Schimpf R, Wolpert C, Gaita F, Giustetto C, Borggrefe M (2005) Short QT syndrome. Cardiovasc Res 67(3):357–366
Brugada R, Hong K, Cordeiro JM, Dumaine R (2005) Short QT syndrome. CMAJ 173(11):1349–1354
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Borchert, B., Lawrenz, T. & Stellbrink, C. Long and short QT syndrome. Herzschr. Elektrophys. 17, 205–210 (2006). https://doi.org/10.1007/s00399-006-0534-9
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s00399-006-0534-9
Schlüsselwörter
- Plötzlicher Herztod
- Molekulare Elektrophysiologie
- Primär elektrische Herzerkrankung
- Langes QT-Syndrom
- Kurzes QT-Syndrom